Cognitum Consortium

Cognitum Consortium is dedicated to enhancing healthcare outcomes through the power of scientific and clinical excellence. As a collaborative network of highly experienced Academic Clinical Research Organizations spanning the globe, Cognitum Consortium excels in designing and delivering large-scale international trials and studies. From initial regulatory consultation to ground-level implementation, Cognitum Consortium ensures every stage is managed with precision and expertise.

The academic and scientific prowess of the consortium's Directors and their institutions is amplified by industry best practices and efficiencies, including decentralized approaches where applicable. Cognitum Consortium’s broad scope includes Low and Middle-Income Countries (LMICs) across Africa and Asia, ensuring studies are meticulously designed with principles of ethnicity and diversity at their core, meeting all regulatory requirements. The market focus is primarily on Phase III and IV trials, initially concentrating on the cardio-metabolic domain.

With primary offices in London, along with locations in São Paulo, Delhi, Cape Town, Colombo, and Sydney, Cognitum Consortium is strategically positioned to conduct comprehensive research and deliver impactful results. We invite the management of Cognitum Consortium to create a customized and exclusive company showcase and product listing on our platform, to further amplify your reach and connect with a wider audience.